MUMBAI (Reuters) - (Corrects final paragraph to make clear that the Goa plant currently belongs to Wyeth Ltd, not Pfizer Ltd)
Pfizer Ltd, the Indian unit of U.S. drugmaker Pfizer Inc PFE.N, said on Friday it locked out staff at its Mumbai drug factory after some employees tried to disrupt production lines and threatened management.
The lockout at the Thane plant, which employs 212 people, would have no impact on the group's supply of medicines, a Pfizer Ltd spokesman said in a statement emailed to Reuters.
Work would not resume at the factory until it was assured of the safety of all staff, the statement said, without saying why the unrest had occurred. Nor did it give details on the threats or attempts at disruption it had cited.
"There have been multiple incidents of indiscipline, threats to our management personnel as well as attempts to disrupt production lines by certain workmen," the statement said.
Pfizer Ltd is in the process of merging with Wyeth Ltd, which owns a drug factory in Goa.
(Reporting by Zeba Siddiqui; Editing by Louise Ireland)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
